Author Guidelines

Download PDFs
Download Templates of Articles
ABOUT THE JOURNAL

International Journal of Advances in Pharmacy Medicine and Bioallied Sciences (Int J Adv Pharm Med Bioallied Sci; IJAPMBS) is an international, multidisciplinary, peer-reviewed, indexed, open access, biomedical journal. IJAPMBS publishes newer dynamic findings in the broad fields of Pharmacy, Medicine, Biotechnology, Life Sciences, Toxicology and other Basic Medical Sciences. The aim of IJAPMBS is to prove an academic communication platform of scientific excellence and information exchange for international physicians, pharmaceutical & medical scientists, allied health personnel, and public health workers.

TOPICS COVERED

Int J Adv Pharm Med Bioallied Sci welcomes submissions from authors worldwide for original research articles, short communications, reviews, mini-reviews, letters to the editor, and case reports relevant to various fields of Pharmacology, Pharmaceutical Medicine (Pharmacy Practice; Hospital, Community and Clinical Pharmacy), Pharmaceutics/Industrial Pharmacy, Pharmaceutical Technology, Nanotechnology, Biopharmaceutics, Pharmacokinetics, Pharmaceutical Chemistry/Medicinal Chemistry/Bulk Drugs, Pharmaceutical Analysis/Quality Assurance, Pharmacognosy & Phytochemistry/Natural Products, Regulatory Affairs & Pharmaceutical Marketing, Biotechnology, Toxicology, Microbiology, Biochemistry and Integrative Medicines etc.

ARTICLE the TYPE SPECIFICATIONS
ARTICLE TYPES ABSTRACT & KEYWORDS WORD LIMIT TABLE AND / FIGURE REFERENCES
Original Research Articles/Regular Paper

Original Research Articles should present new clinical and pre-clinical studies that represent a significant contribution to existing knowledge. These must illustrate significant and original observations and provide satisfactory details so that the observations can be critically evaluated and if required, repeated.

Structured abstract:

  • Background
  • Material/Subject and methods
  • Results
  • Conclusions

Keywords: 3–6.

Abstract: 300 words Article: Max of 4,500 words (excluding abstract, references, figures & tables). Max of 8 (Total) 60 max
Short Communications

These are studies that fall short of the criteria for full Original Research Articles (e.g. preliminary experiments limited by sample size or duration, or novel hypotheses). Apart from including an abstract, there is no obligation to divide the text into sections.

Unstructured abstract, Keywords: 3–6. Abstract: 200 words,Article: Max of 2,500 words(excluding abstract, references, figures and tables). Max of 4 (Total) 20 max
Reviews

It should be a comprehensive analysis of specific topics over the previous five years providing the trend and direction of future research on the subject matter. These should not be simple anthology on subjects of general interest.

Unstructured abstract, Keywords: 3–6. Abstract: 250 wordsArticle:Max of 6,000 words(excluding abstract, references, figures and tables). Max of 8 (Total) 60 max
Mini-Reviews

It should be a comprehensive analysis on the specific topic of advance interest.

Unstructured abstract, Keywords: 3–6. Abstract:200 wordsArticle:Max of 2,500 words (excluding abstract, references, figures and tables). Max of 4 (Total) 30 max
Letters to the Editor

Editorial Letters should be short and significant observations. Editorial Letters must contain information critical to a certain area or must be referencing data recently published in IJAPMBS.

They should not be preliminary findings that need a subsequent paper for validation.

No abstract, No keywords Max of 500 words (excluding references). Nil 10 max
Case Reports

Interesting clinical cases (with pharmacologic significance) may be considered for publication. Those with photographs stand a better chance. The case reports should have an unstructured Abstract, Introduction, Case Presentation, Discussion, and Conclusion. Note: Submit consent from patient for case report publication

Unstructured abstract (including background, case presentation, conclusion). Keywords: 3–6. Abstract: 100 words; Article: Max of 1000 words (excluding abstract, references, figures and tables) Max of 3 (Total) 20 max
AUTHOR’S CONTRIBUTION
It is recommended to mention the contribution of each author of an article to provide the appropriate credit individually. Contributors should give detailed contributions made by each author like rationale, concept, design, literature review, experimental studies, data-analysis and presentation, statistical analysis, manuscript-designing, editing and review.
MANUSCRIPT PREPARATION
GENERAL STYLE: The manuscript should be typed in MS–word format using a font size of 12 in “Times New Roman” font, single-spaced, with 8” (inches) wide margins, on A-4 size paper as single columns. Title shall be in a font size 14 while all section titles in the manuscript shall be in font size 12, bold face, sentence case. All pages, including the title page, must be numbered consecutively. No specific enhancements (underlining, capitalization, wider margins, different spacing, etc.) should be employed in the manuscript structure. New paragraphs should not be indented. All the tables and figures should be embedded in the text at suitable positions.

MANUSCRIPT COMPONENTS: The original articles must contain the following components:

  • Cover letter
  • Title page
  • Abstract and keywords
  • Introduction
  • Material (or Subject) and methods
  • Results
  • Discussion
  • Conclusions
  • Acknowledgments
  • Conflict of interest
  • References
COVER LETTER: The enclosed covering letter must state the material is original, has not been published earlier and has not been submitted for publication somewhere else while under consideration.
Secondly, authors must state the scientific data and information are not copied from the other published papers to avoid plagiarism (i.e. use or close reproduction of the language and thoughts of another author and the representation of them as one’s own original work) issues. Further, add a note about including conflict of interest statement. Lastly, provide the contribution of each author in the article.

Note:

  1. It is requested to provide the details (Name, qualification, designation, address, and e-mail ID) of two referees to speed up the peer-review process.
  2. Cover letter must be signed by all author(s) & scanned.
  3. Authors may suggest the name(s) and e-mail IDs of such referees to whom their manuscripts should not be sent for peer-review process.

TITLE PAGE: The title page should provide the brief and informative title (150 characters or less) and the running head (up to 60 characters, including spaces) of the paper, the full name(s) of all the authors [first name, middle initial (if any), last name] and their affiliations [full postal address(es) (city, street, zip code, and country of the affiliated institution(s)] in which the work was performed, together with the name, full postal address, and e-mail address of the author to whom correspondence are to be sent. The corresponding author of the manuscript must be indicated by an asterisk (*).

ABSTRACT AND KEYWORDS: Abstract should be typed on next to title page separately. The structured abstract should briefly describe the essential features of the paper in a logical and concise sequence with following headings: Background/Objective(s), Methods/Subjects, Results, and Conclusions. References should not be included. Provide up to six keywords if possible which best describe your article.

INTRODUCTION: Introduction should start on a new page providing the problem/background/rationale, and should clearly indicate the aim of the study. The introduction should be concise but can include a short historical review of recent publications.

MATERIAL (OR SUBJECT) AND METHODS: This section should provide sufficient details of nomenclature, source of material and procedures, so that all experimental procedures can be reproduced. New methods should be described in sufficient detail while methods already published should be indicated by a reference. Authors should provide the source of the chemicals, drugs, medical equipment, and instruments. All the drugs should be identified by their pharmaceutical name(s), and trade name(s) if relevant. The basis for dose selection (free form or salt) should be indicated. In addition, the sex, strain, and approximate weight of animals should be provided, and the housing and feeding conditions should be briefly illustrated. The route of administration (po, iv, ip, icv), the solvent used, etc. should be specified. Proof for approval by a local Ethics Committee (for both humans as well as animal studies) must be provided by the authors on demand. Authors must give the details of ethical approval for animal experiments. Preliminary phytochemical screening of extracts and/or fractions tested for in vitro or in vivo biological activities should be defined. Complete details of the formulation of each crude drug mixture and extracts should be depicted. The statistical method and the level of significance chosen should be clearly mentioned.

RESULTS: The experimental observations and data should be presented in unified and coherent sequence so that the report develops clearly and logically with appropriate reference to tables and/or figures. The presented data should be statistically analyzed, and the level of significance should be stated. The same data should be given either in tabular or graphic forms. However, data presented in chart form (column, line, pie, bar, area, scatter and other charts) should include the depiction of values. The data presented in tables or figures should not be repeated in the text. Simple data (i.e. only a few numerical data) may be presented in the body text.

DISCUSSION: The discussion section should explore the significance of the results of the work. It should focus on what way the present study is important and what have been added in the existing knowledge. Relate your findings to others published work in the area. Extensive citations and discussion of published literature should be avoided. There should not be repeatedly copying of results in the discussion section.

CONCLUSIONS: In a separate section, the major interpretations of the study and their importance shall be summarized. It should also mention the new hypotheses or recommendations to be put forth. Unqualified statements and conclusions which are not completely supported by the data should be avoided. It is important to correlate the conclusions with the objectives stated under introduction section.

ACKNOWLEDGMENTS: Acknowledgments should be brief and for sources of support, including sponsorship (e.g. university, charity, commercial organization, funding agencies) and sources of material (e.g. novel drugs) not available commercially only, not for providing routine facilities, etc.

CONFLICT OF INTEREST: All authors of the manuscript must declare whether or not there are any competing financial interests in relation to the work described in a separate section.

REFERENCES: It should begin as a separate section. It should begin as a separate section. References should follow the author-date citations format (Harvard style) e.g. (Rub et al., 2009) in the text. List here all the references in alphabetical order of citation in the text. List all authors if less than six. If more than six authors list the first six followed by “et al.”]
The general style of reference is:
[Surname First Name Middle Name, Surname First Name Middle Name. Title of article. Journal full name. Year;Volume(Number if any):Full inclusive page numbers.] For Example:
Ansari MA, Razdan RK. Relative efficacy of insecticide-treated mosquito nets (Diptera: Culicidae) under field conditions. Journal of Medical Entomology. 2000;37:201-204.
Rub A, Dey R, Jadhav M, Kamat R, Chakkaramakkil S, Majumdar S, et al. Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function. Nature Immunology. 2009;10:273-280.

Citation in Text: It is important to ensure that every reference cites in the text is also present in the reference list (and vice versa).
Citation in List:.
All citations in the text and list should meet the following format:

  • JOURNAL ARTICLE
  • Single author

  • (Ansari, 2010)
  • Ansari JA. Drug interaction and pharmacist. Journal of Young Pharmacists. 2010;2:326-331.
  • Two authors

  • (Ansari and Razdan, 2000)
  • Ansari MA, Razdan RK. Relative efficacy of insecticide-treated mosquito nets (Diptera: Culicidae) under field conditions. Journal of Medical Entomology. 2000;37:201-204.
  • More than six authors

  • (Rub et al., 2009)
  • Rub A, Dey R, Jadhav M, Kamat R, Chakkaramakkil S, Majumdar S, et al. Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function. Nature Immunology. 2009;10:273-280.
  • Journal Article: Article Number

  • (Wen et al., 2011)
  • Wen Z, Wang Z, Wang S, Ravula R, Yang L, Xu J, et al. Discovery of molecular mechanisms of traditional Chinese medicinal formula Si-Wu-Tang using gene expression microarray and connectivity map. PLoS One. 2011;6:e18278.
  • BOOK AND eBOOK

    Book/eBook

  • (Pepperberg, 1999)
  • Pepperberg IM. The Alex studies: Cognitive and communicative abilities of grey parrots. Cambridge, Mass.: Harvard University Press; 1999.
  • Book Section

  • (Clayton and Emery, 2009)
  • Clayton NS, Emery NJ. What do jays know about other minds and other times? In: Berthoz A, Christen Y, editors. Neurobiology of Umwelt: How Living Beings Perceive the World. Berlin: Springer-Verlag Berlin; 2009. p. 109-23.
  • Chapter or Article in Edited Book

  • (Brown, 2011)
  • Brown DA. G-Proteins. In: Foreman JC, Johansen T, Gibb AJ, editors. Textbook of Receptor Pharmacology. Boca Raton, F.L.: CRC Press; 2011. P. 199-224.
  • WEB PAGE

    Web page: Organization as author

  • (EUROBATS Secretariat, 2004)
  • EUROBATS Secretariat. EUROBATS: The Agreement on the Conservation of Populations of European Bats. EUROBATS; 2004. [http://www.eurobats.org/] (Accessed on July 2005)
  • Web page: No author

  • (Anonymous, 2005)
  • Anonymous. The clinical Evaluation of the QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; 2005. [http://www.ich.org] (Accessed 25 January 2006).
  • PATENT

  • (Das and Cohly, 1996)
  • Das SK, Cohly HHP. Use of turmeric in wound healing. US Patent 5,401,504; 1995.

    CONFERENCE PROCEEDING

  • (Hagino et al., 2007)
  • Hagino T, Hiryu S, Fujioka S, Riquimaroux H, Watanabe Y. Adaptive SONAR sounds by echolocating bats. 5th International Symposium on Underwater Technology. Tokyo, Japan: IEEE; 2007. p. 647-51.
  • PRESS RELEASE

  • (The Alex Foundation, 2007)
  • The Alex Foundation. Alex the African grey parrot and subject of landmark studies of bird intelligence dies at 31. Waltham, MA: The Alex Foundation; 2007.
  • PODCAST

  • (Seftel, 2011)
  • Seftel J. Profile: Irene Pepperberg & Alex. In: Tyson NdG, editor. NOVA Science Video Podcast. Boston: WGBH; 2011.
  • EndNote Referencing
    EndNote users can contact editorial (editorbiomedjournal@gmail.com) for EndNote file of “Int J Adv Pharm Med Bioallied Sci” style.

    Figures and illustrations: Self-explanatory figures and illustrations (photographs, drawings, diagrams and charts) should be embedded in text at the suitable place in numerical order using Arabic numerals and abbreviated as Fig. However, it is recommended to submit the figures and illustrations in PNG, TIFF, JPG, JPEG, EPS etc. as separate files also. Each illustration should have a brief and specific caption and legend (a brief title and a description of the illustration). 3D histograms are not recommended if the third dimension gives no additional information. Illustrations from other publications should be with prior permission only. For all articles, there is normally a limit of 5 figures and tables (total) per manuscript. However, figures/illustrations can be clubbed and depicted in groups like Figure 1A, 1B………etc.

    Tables: Self-explanatory tables should be labeled sequentially using Arabic numerals bearing brief title and cited within the text at the suitable place. Place essential footnotes to tables in the table body and indicate them with superscript lowercase letters. Tables should contain vertical as well as horizontal rules. For all articles, there is normally a limit of 5 figures and tables (total) per manuscript.

    MANUSCRIPT SUBMISSION

    Pre-submission inquiries: Pre-submission and all other inquiries (if any) should be made by email to the Editorial Office at editorbiomedjournal@gmail.com.

    Online submission: All the manuscript in the MS word format embedded with Table and Figures as a single file should be sent by email to the Editorial Office at editorbiomedjournal@gmail.com. However, it is recommended to submit Figures separately as well. Submission is free of charge and must be completed via online submission or through e-mail. Submission will be confirmed by an acknowledgment reply e-mail from Editorial Office.

    Authors may submit the names and full contact details (including e-mail address) of two potential referees with their manuscripts. It is the responsibility of the author to ensure that papers are written in clear and comprehensible English.

    Decision on submission: Decision on the submitted articles will be taken after completion of the peer-review process which will not exceed one month.

    Submission of revisions: Revised manuscripts should be submitted to the Editorial Office at editorbiomedjournal@gmail.com along with point to the point answers of comments raised by the reviewer. Changes made in response to the reviewers’ comments should be highlighted by yellow color in ‘Revised Manuscripts’.

    Note: Authors are requested to submit their articles strictly as per the given format mentioned in the ‘Author Guidelines’.

    POST ACCEPTANCE

    Galley proofs: After acceptance, proofs will be sent to the corresponding author in PDF for final proofreading and appropriate corrections that should be returned via e-mail within a week of receipt. No additions and revisions will be entertained other than the correction of typographical errors.

    Early view: The final version of the manuscript will be published online in advance of next issue soon after receiving the galley proofs.

    Re-prints: PDF files will be provided to the corresponding author via e-mail at free of cost at the time of publication of the respective issue. However, articles will be available free of charge on the journal’s website.

    EDITORIAL POLICIES

    AUTHORSHIP: All categories of articles should conform the requirements developed by the ICMJE (www.icmje.org) “Uniform Requirements for Manuscripts Submitted to Biomedical Journals”.

    PLAGIARISM: Plagiarism is the ‘use or close reproduction of the language and thoughts of another author and the representation of them as one’s own original work’. Simply copying scientific data and information from the other published papers and pasting the manuscript is the unlawful practice in academic fraternity. Therefore, it is requested to all the authors to adopt the holistic & pragmatic approach to design the manuscript. If plagiarism is reported, the journal will contact the author’s Institute/labs and funding agencies.

    PEER-REVIEW: All manuscripts will be sent out for confidential peer-review by experts in the field and, based on reviewer’s response, papers will be accepted as it is or accepted with minor/major revision or rejected.

    ETHICS AND CONSENT: Studies involving human participants must be conducted in accordance with the Declaration of Helsinki and guidelines on Good Clinical Practice. Further, authors are advised to state about the approval of regional/national/ institutional or independent Ethics Committee or Review Board, obtaining informed consent from adult research participating in the trial. Ethics prepared by INSA, Animal Welfare Division of the Ministry of Environment & Forest, Council of International Organisation of Medical Sciences (WHO/UNESCO), NIH and PHS for the vertebrate animal experimental model should be followed by authors.

    COPYRIGHT: Submission of the manuscript to this journal implies that the same has not been published earlier and/or is not considered for publication elsewhere in any form or language except abstract. Authors would be required to sign a Copyright Transfer form, prior to publication at the acceptance of the manuscript.

    DISCLAIMER: No responsibility is assumed by the IJAPMBS for any grievance and/or damage to persons or property as a matter of product’s liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the manuscript. The respective individual author(s) will be responsible for the facts/views expressed in their articles.

    ————————————————————————————————————-

    COPYRIGHT TRANSFER FORM

    I have studied the above mentioned details related to copyright of the article submitted and I (name)____________________________________________,the corresponding author of (Title of manuscript)________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________certify that I/We willingly assign the copyright of my/our article (Type of Article)____________________________________________________to the IJAPMBS, who will have the exclusive right of producing the complete work or any portion of it.
    I/ We hereby certify that the data which I/we am/are submitting to the publisher is my own and does not contain any matter, which in any way is a contravention of the copyright law.
    S No.; Name of author(s); Affiliation (Address); Signature(s)
    1.
    2.
    3.
    4.
    5.
    6.
    7.
    8.
    etc.

    DECLARATION: While submitting the articles the corresponding author should declare (on the behalf of co-authors) that the material is original, has not been published earlier and has not been submitted for publication somewhere else while under consideration.

    Corresponding author
    Signature:………………………………
    Date:………………………………………
    Mobile No. ………………………………………
    Email ID: ……………………………………………………………

    ————————————————————————————————————-
    MANUSCRIPT SUBMISSION, PROCESSING AND PUBLICATION CHARGES
    Outstanding original research articles will be processed and published free of charge. However, other articles may be charged a nominal cost of Rs 1000/- (for Indian authors) or £40/$45/€45/SAR175/JPY5300 (for foreign authors) per article as cost towards the maintenance of article in secured data storage system, databases etc. The cost is to be deposited only after receiving the acceptance of the article. J Adv Pharm Med Bioallied Sci (IJAPMBS) usually waive charges (full/part) on a case-by-case basis to the author(s) with insufficient funds/stipend/scholarship. Author(s) may apply for a waiver or discount during the submission process.
    CHECKLIST
    • Covering letter (including author’s contribution, funding sources, conflicts of interest disclosure, declaration by authors).
    • Author’s name and affiliations.
    • Author for correspondence, with the e-mail address, and contact number.
    • Keywords
    • All figures along with captions and legends embedded in manuscript.
    • Figures attached in an acceptable format (TIFF, JPG, JPEG, EPS) as separate files also.
    • All tables (including title, description, footnotes) embedded in manuscript.
    • Table plus figures/illustrations are not more than 5 (total) per manuscript.
    • Tables should contain vertical as well as horizontal rules.
    • The manuscript has been checked for anti-plagiarism.
    • The manuscript has been ‘spell-checked’ and ‘grammar-checked’.
    • References are in the correct format for this journal.
    • All references mentioned among the Reference list are cited within the text and vice versa.
    • Conflicts of interest disclosure have been mentioned in the manuscript.
    • Checked for plagiarism.
    CONTACT US
    Dr. Javed Akhtar Ansari
    Editor-in-Chief,
    International Journal of Advances in Pharmacy Medicine and Bioallied Sciences,
    [Int J Adv Pharm Med Bioallied Sci (IJAPMBS)],
    Ashrafi Manzil, Badlu Rangari Street, Byculla West,
    Mumbai-400008, India.